Cite
HARVARD Citation
Oliva-Damaso, N. et al. (2021). Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO. Kidney360. 2 (11), pp. 1696-1698. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Oliva-Damaso, N. et al. (2021). Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO. Kidney360. 2 (11), pp. 1696-1698. [Online].